Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31
196 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
196
Total Reports
20
Deaths Reported
1020.0%
Death Rate
Active Ingredients
Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 196
Most Affected Breeds
Retriever - Labrador 25
Shih Tzu 12
Terrier - Bull - American Pit 10
Terrier - Yorkshire 10
Retriever - Golden 9
Boxer (German Boxer) 8
Terrier - Jack Russell 7
Crossbred Canine/dog 6
Beagle 6
Chihuahua 6
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 61
Vomiting 57
Anorexia 36
Anaphylactoid reaction 34
Other abnormal test result NOS 25
Facial swelling (see also 'Skin') 22
Diarrhoea 22
Urticaria 19
Emesis 15
Lameness 15
Injection site swelling 14
Fever 14
Outcome Breakdown
Ongoing
107 (54.6%)
Recovered/Normal
60 (30.6%)
Euthanized
13 (6.6%)
Outcome Unknown
9 (4.6%)
Died
7 (3.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.